LRRK2 expression linked to dopamine-innervated areas

被引:152
作者
Galter, D
Westerlund, M
Carmine, A
Lindqvist, E
Sydow, O
Olson, L
机构
[1] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
[2] Karolinska Univ Hosp, Neurol Sect, Dept Clin Neurosci, Stockholm, Sweden
关键词
D O I
10.1002/ana.20808
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective : Leucine-rich repeat kinase 2 (LRRK2) has been linked to Parkinson's disease. Our study explores the expression of LRRK2 in human and rodent brain tissue. Methods: We analyzed LRRK2 gene activity at the cellular level using in situ hybridization. Results. We found a high and strikingly specific expression of LRRK2 mRNA in rodent striatum and parts of cortex and no signals in dopamine neurons. In human tissue, LRRK2 mRNA was found in the corresponding brain areas caudatus and putamen at lower levels and dopamine neurons were also devoid of LRRK2 mRNA. Expression levels in striatal tissue did not differ between Parkinson's disease patients and control subjects. Interpretation : Unlike all other genes so far linked to Parkinson's disease, our results demonstrate that LRRK2 expression is particularly high in brain dopaminoceptive areas.
引用
收藏
页码:714 / 719
页数:6
相关论文
共 15 条
  • [1] BLACKINTON JG, 2004, CELLULAR EXPRESSION
  • [2] Stages in the development of Parkinson's disease-related pathology
    Braak, H
    Ghebremedhin, E
    Rüb, U
    Bratzke, H
    Del Tredici, K
    [J]. CELL AND TISSUE RESEARCH, 2004, 318 (01) : 121 - 134
  • [3] Buervenich S, 2000, MOVEMENT DISORD, V15, P813, DOI 10.1002/1531-8257(200009)15:5<813::AID-MDS1008>3.0.CO
  • [4] 2-Y
  • [5] A rare truncating mutation in ADH1C (G 78Stop) shows significant association with Parkinson disease in a large international sample
    Buervenich, S
    Carmine, A
    Galter, D
    Shahabi, HN
    Johnels, B
    Holmberg, B
    Ahlberg, J
    Nissbrandt, H
    Eerola, J
    Hellström, O
    Tienari, P
    Matsuura, T
    Ashizawa, T
    Wüllner, U
    Klockgether, T
    Zimprich, A
    Gasser, T
    Hanson, M
    Waseem, S
    Singleton, A
    McMahon, FJ
    Anvret, M
    Sydow, O
    Olson, L
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (01) : 74 - 78
  • [6] Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease
    Carmine, A
    Buervenich, S
    Sydow, O
    Anvret, M
    Olson, L
    [J]. MOVEMENT DISORDERS, 2002, 17 (04) : 764 - 766
  • [7] SENSITIVE MESSENGER-RNA DETECTION USING UNFIXED TISSUE - COMBINED RADIOACTIVE AND NONRADIOACTIVE INSITU HYBRIDIZATION HISTOCHEMISTRY
    DAGERLIND, A
    FRIBERG, K
    BEAN, AJ
    HOKFELT, T
    [J]. HISTOCHEMISTRY, 1992, 98 (01) : 39 - 49
  • [8] GALTER D, 2005, IN PRESS PHYSL BEHAV
  • [9] Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia:: role of D3 and not D2 receptors
    Joyce, JN
    Ryoo, HL
    Beach, TB
    Caviness, JN
    Stacy, M
    Gurevich, EV
    Reiser, M
    Adler, CH
    [J]. BRAIN RESEARCH, 2002, 955 (1-2) : 138 - 152
  • [10] Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
    Paisán-Ruíz, C
    Jain, S
    Evans, EW
    Gilks, WP
    Simón, J
    van der Brug, M
    de Munain, AL
    Aparicio, S
    Gil, AM
    Khan, N
    Johnson, J
    Martinez, JR
    Nicholl, D
    Carrera, IM
    Pena, AS
    de Silva, R
    Lees, A
    Martí-Massó, JF
    Pérez-Tur, J
    Wood, NW
    Singleton, AB
    [J]. NEURON, 2004, 44 (04) : 595 - 600